We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cracking Down on Fake Diabetes/Weight Loss Drugs in Warning Letters
FDA Cracking Down on Fake Diabetes/Weight Loss Drugs in Warning Letters
Two online marketers of semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) received FDA warning letters for selling the unapproved, untested drugs to consumers through their websites.